Merit Medical Systems, Inc’s recently made public that its Officer FRED LAMPROPOULOS acquired Company’s shares for reported $38244.0 on Jun 10 ’25. In the deal valued at $95.61 per share,400 shares were bought.
Then, Lampropoulos Fred P. sold 10,000 shares, generating $951,900 in total proceeds. Upon selling the shares at $95.19, the President and CEO now owns 1,046,028 shares.
Before that, FRED LAMPROPOULOS bought 10,000 shares. Merit Medical Systems, Inc shares valued at $951,940 were divested by the Officer at a price of $95.19 per share.
JP Morgan initiated its Merit Medical Systems, Inc [MMSI] rating to an Overweight in a research note published on March 28, 2025; the price target was $120. A number of analysts have revised their coverage, including Wells Fargo’s analysts, who increased its forecast for the stock in mid December from “an Equal weight” to “an Overweight”. Robert W. Baird began covering MMSI with “an Outperform” recommendation on June 28, 2024. CL King started covering the stock on April 11, 2024. It rated MMSI as “a Buy”.
Price Performance Review of MMSI
On Tuesday, Merit Medical Systems, Inc [NASDAQ:MMSI] saw its stock jump 0.35% to $95.17. Over the last five days, the stock has gained 0.60%. Merit Medical Systems, Inc shares have fallen nearly -1.60% since the year began. Nevertheless, the stocks have risen 13.89% over the past one year.
How much short interest is there in Merit Medical Systems, Inc?
A steep rise in short interest was recorded in Merit Medical Systems, Inc stocks on 2025-05-15, dropping by 95879.0 shares to a total of 3.15 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 3.25 million shares. There was a decline of -3.04%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on February 07, 2024 when BofA Securities began covering the stock and recommended ‘”a Neutral”‘ rating along with a $87 price target.
